RESEARCH-USE BIOSIMILAR ANTIBODY
Leronlimab
Monoclonal antibody · IgG4
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer.
TARGETCCR5
YMonoclonal antibody
CATALOGSC-BS-442
CATALOG NUMBERSC-BS-442
MOLECULAR WEIGHTApprox. 146.7 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer.
Leronlimab is a recombinant research-use antibody directed against CCR5.